{"title":"secukinumab治疗(150和300 mg)对中重度斑块型银屑病患者的实际疗效和安全性:一项为期12周的单中心回顾性研究","authors":"Incilay Kalay Yildizhan, M. Aygun, N. Kundakçı","doi":"10.4274/turkderm.galenos.2021.70446","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":49412,"journal":{"name":"Turkderm-Archives of the Turkish Dermatology and Venerology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"The real-life efficacy and safety of secukinumab therapy (150 and 300 mg) in patients with moderate-to-severe plaque psoriasis: A twelve week, single center, retrospective study\",\"authors\":\"Incilay Kalay Yildizhan, M. Aygun, N. Kundakçı\",\"doi\":\"10.4274/turkderm.galenos.2021.70446\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":49412,\"journal\":{\"name\":\"Turkderm-Archives of the Turkish Dermatology and Venerology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Turkderm-Archives of the Turkish Dermatology and Venerology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4274/turkderm.galenos.2021.70446\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Turkderm-Archives of the Turkish Dermatology and Venerology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4274/turkderm.galenos.2021.70446","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
The real-life efficacy and safety of secukinumab therapy (150 and 300 mg) in patients with moderate-to-severe plaque psoriasis: A twelve week, single center, retrospective study